O39. In vitro cellular radiosensitivity assays as predictor of radiotherapy related late toxicity in breast cancer patients
Introduction About 5% of cancer patients receiving radiation therapy (RT) exhibit severe normal tissue reactions. The prediction of late toxicity in cancer patients would enable individualized and optimized radiation dose prescription. In this study, four different candidate in vitro cellular radios...
Saved in:
Published in | Physica medica Vol. 32; pp. 153 - 154 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.09.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction About 5% of cancer patients receiving radiation therapy (RT) exhibit severe normal tissue reactions. The prediction of late toxicity in cancer patients would enable individualized and optimized radiation dose prescription. In this study, four different candidate in vitro cellular radiosensitivity assays for prediction of late normal tissue reactions were evaluated in a retrospective matched case-control set-up of breast cancer patients. Materials and methods Breast cancer patients expressing severe radiation toxicity (12 cases) and no or minimal reactions (12 controls) with a follow-up of at least 3 years were selected for this study. Case and control patients were matched for therapy and patient related variables. After in vitro irradiation of patient blood samples, case and control radiation responses were compared for the following biological end points: radiation-induced CD8+ late apoptosis, residual DNA double strand breaks (DSB), G0 and G2+caf micronucleus assay. Results Despite a substantial overlap in standard deviations, all cellular assays showed a significant difference between cases and controls. Less radiation-induced apoptosis was observed in CD8+ lymphocytes of cases (14.45%) compared to the matched controls (30.64%) ( p < 0.01). The number of residual DNA DSB was higher in cases (9.92 foci/cell) compared to their matched controls (9.17 foci/cell) ( p < 0.01). The average dose response curve of the G0 MN assay for cases lies above the average dose response curve of the controls. Finally, a pairwise comparison of the G2+caf MN results showed a higher MN yield for cases (351 MN/1000BN) compared to controls (219 MN/1000BN) ( p < 0.01). Conclusion Current results suggest that intrinsic radiosensitivity is involved in the development of late radiotoxic effects. Larger prospective studies are warranted to validate the retrospective findings in order to use in vitro cellular assays in the future to predict late normal tissue radiosensitivity in clinical practice. |
---|---|
AbstractList | Introduction About 5% of cancer patients receiving radiation therapy (RT) exhibit severe normal tissue reactions. The prediction of late toxicity in cancer patients would enable individualized and optimized radiation dose prescription. In this study, four different candidate in vitro cellular radiosensitivity assays for prediction of late normal tissue reactions were evaluated in a retrospective matched case-control set-up of breast cancer patients. Materials and methods Breast cancer patients expressing severe radiation toxicity (12 cases) and no or minimal reactions (12 controls) with a follow-up of at least 3 years were selected for this study. Case and control patients were matched for therapy and patient related variables. After in vitro irradiation of patient blood samples, case and control radiation responses were compared for the following biological end points: radiation-induced CD8+ late apoptosis, residual DNA double strand breaks (DSB), G0 and G2+caf micronucleus assay. Results Despite a substantial overlap in standard deviations, all cellular assays showed a significant difference between cases and controls. Less radiation-induced apoptosis was observed in CD8+ lymphocytes of cases (14.45%) compared to the matched controls (30.64%) ( p < 0.01). The number of residual DNA DSB was higher in cases (9.92 foci/cell) compared to their matched controls (9.17 foci/cell) ( p < 0.01). The average dose response curve of the G0 MN assay for cases lies above the average dose response curve of the controls. Finally, a pairwise comparison of the G2+caf MN results showed a higher MN yield for cases (351 MN/1000BN) compared to controls (219 MN/1000BN) ( p < 0.01). Conclusion Current results suggest that intrinsic radiosensitivity is involved in the development of late radiotoxic effects. Larger prospective studies are warranted to validate the retrospective findings in order to use in vitro cellular assays in the future to predict late normal tissue radiosensitivity in clinical practice. About 5% of cancer patients receiving radiation therapy (RT) exhibit severe normal tissue reactions. The prediction of late toxicity in cancer patients would enable individualized and optimized radiation dose prescription. In this study, four different candidate in vitro cellular radiosensitivity assays for prediction of late normal tissue reactions were evaluated in a retrospective matched case-control set-up of breast cancer patients. Breast cancer patients expressing severe radiation toxicity (12 cases) and no or minimal reactions (12 controls) with a follow-up of at least 3 years were selected for this study. Case and control patients were matched for therapy and patient related variables. After in vitro irradiation of patient blood samples, case and control radiation responses were compared for the following biological end points: radiation-induced CD8+ late apoptosis, residual DNA double strand breaks (DSB), G0 and G2+caf micronucleus assay. Despite a substantial overlap in standard deviations, all cellular assays showed a significant difference between cases and controls. Less radiation-induced apoptosis was observed in CD8+ lymphocytes of cases (14.45%) compared to the matched controls (30.64%) (p<0.01). The number of residual DNA DSB was higher in cases (9.92 foci/cell) compared to their matched controls (9.17 foci/cell) (p<0.01). The average dose response curve of the G0 MN assay for cases lies above the average dose response curve of the controls. Finally, a pairwise comparison of the G2+caf MN results showed a higher MN yield for cases (351 MN/1000BN) compared to controls (219 MN/1000BN) (p<0.01). Current results suggest that intrinsic radiosensitivity is involved in the development of late radiotoxic effects. Larger prospective studies are warranted to validate the retrospective findings in order to use in vitro cellular assays in the future to predict late normal tissue radiosensitivity in clinical practice. |
Author | Sebastià, N De Langhe, S Wieme, G Thierens, H De Neve, W Baert, A Vandevoorde, C Philippé, J Depuydt, J Veldeman, L Vral, A |
Author_xml | – sequence: 1 fullname: Vandevoorde, C – sequence: 2 fullname: Depuydt, J – sequence: 3 fullname: Veldeman, L – sequence: 4 fullname: De Neve, W – sequence: 5 fullname: Sebastià, N – sequence: 6 fullname: Wieme, G – sequence: 7 fullname: Baert, A – sequence: 8 fullname: De Langhe, S – sequence: 9 fullname: Philippé, J – sequence: 10 fullname: Vral, A – sequence: 11 fullname: Thierens, H |
BookMark | eNp9kctq3TAQhkVJoclpX6ArvYAdjWRbNoRCCc0FAlm0he6EznhM5TiSkZRQ05evzOmqi27mwsw3zPxzwc588MTYRxA1COgu55rm57WWJa6FrkWj37Bz0LKpYIAfZyUGKSrQg37HLlKahVBStu05-_2ohprfe_7qcgwcaVleFht5tKMLiXxy2ZXSxm1KdkvF8TXS6DCHyMN06ss_Kdp145EWm2nku-U5_HK4k87zYySbMkfrkSJfbXbkc3rP3k52SfThrz-w7zdfvl3fVQ-Pt_fXnx8qhBZ0pSboRzwijHJouq5H3amhp2Y49krDINq2k0ITta1CiyXVKEYxtlL3qpkGUgcmT3MxhpQiTWaN7tnGzYAwu3xmNrt8ZpfPCG2KfAW6OkFUNnt1FE3CsjWW2yNhNmNw_8c__YPj4rxDuzzRRmkOL9GXmw2YJI0wX_f_7O-BTgnoRaf-ALPSkWs |
ContentType | Journal Article |
Copyright | 2016 |
Copyright_xml | – notice: 2016 |
DBID | AAYXX CITATION |
DOI | 10.1016/j.ejmp.2016.07.047 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1724-191X |
EndPage | 154 |
ExternalDocumentID | 10_1016_j_ejmp_2016_07_047 S1120179716301806 1_s2_0_S1120179716301806 |
GroupedDBID | --- --K --M -QF .1- .FO .~1 0R~ 123 1B1 1P~ 1~. 1~5 3J0 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABNEU ABXDB ACDAQ ACFVG ACGFS ACNNM ACRLP ACXCU ADBBV ADEZE ADVLN AEBSH AEFWE AEKER AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AIVDX AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CLCPZ CS3 DC1 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OGIMB OI~ OU0 OZT P-8 P-9 PC. Q38 RLW ROL RPZ SDF SDG SEL SES SJN SPC SPCBC SSH SSQ SSZ T5K UNMZH Z5R ~G- ~XS AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX CITATION |
ID | FETCH-LOGICAL-c1517-3f18dcbc1d294668c76398e49b837190556207ee553cac0557c0d0d527834f9e3 |
IEDL.DBID | AIKHN |
ISSN | 1120-1797 |
IngestDate | Thu Sep 26 15:26:16 EDT 2024 Fri Feb 23 02:28:26 EST 2024 Tue Oct 15 22:56:10 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1517-3f18dcbc1d294668c76398e49b837190556207ee553cac0557c0d0d527834f9e3 |
PageCount | 2 |
ParticipantIDs | crossref_primary_10_1016_j_ejmp_2016_07_047 elsevier_sciencedirect_doi_10_1016_j_ejmp_2016_07_047 elsevier_clinicalkeyesjournals_1_s2_0_S1120179716301806 |
PublicationCentury | 2000 |
PublicationDate | September 2016 |
PublicationDateYYYYMMDD | 2016-09-01 |
PublicationDate_xml | – month: 09 year: 2016 text: September 2016 |
PublicationDecade | 2010 |
PublicationTitle | Physica medica |
PublicationYear | 2016 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
SSID | ssj0032255 |
Score | 2.084669 |
Snippet | Introduction About 5% of cancer patients receiving radiation therapy (RT) exhibit severe normal tissue reactions. The prediction of late toxicity in cancer... About 5% of cancer patients receiving radiation therapy (RT) exhibit severe normal tissue reactions. The prediction of late toxicity in cancer patients would... |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 153 |
SubjectTerms | Radiology |
Title | O39. In vitro cellular radiosensitivity assays as predictor of radiotherapy related late toxicity in breast cancer patients |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1120179716301806 https://dx.doi.org/10.1016/j.ejmp.2016.07.047 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS-RAEC50BNmL-Fp2fNEHb5KdZNJJJ0cRZVTUywremvQjEGGTIYmiCP52q6Y7srLiwUtCQooOleqqrztVXwEcGlXmqYrDINNpGnAhbJAXuggKpbUVcW5FSbXDV9fp7JZf3CV3S3Ay1MJQWqX3_c6nL7y1vzPx2pzMq2qC83BK5oSAPyYWqnQZVjAccT6ClePzy9n14JDJZJNFjxVcKZGAr51xaV72_i_RVkaOw5O6rHwWn_6JOWfrsObBIjt277MBS7behNUr_zt8C15u0AbZec0eq75tGG3CU1YpawtTNR2lprveEAwRcvHc4YnNW5LGhTZrSvecq8B6ZouqFmsYHVnfPOEYKFnVTFHees802UfLPBFrtw23Z6d_TmaB76YQaIzq6EnKKDNa6chMiVM-0-hZ8szyXOEaFWFBgkgoFNYmSawLTdRcOjShSRatOMrcxj9hVDe1_QUs4bHOEO8SMRBXpciVmZpQ80wh3OGRGMPRoEM5d6QZcsgmu5ekcUkal6GQqPExiEHNcigHRQdmOz-bOhnJbipD-d8XH0PyLvnBaCTGgy9G3Pmm3C78oCuXYrYHo759sPuISXp1AMu_X6MDb3lvod3hZA |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS-RAEC58gO5FfLLjY-2DN4mTTB6dHEWUcXX0ouCtST8CETYZkqwowv72rUp3RFH2sJcEki46VKqrvk6-qgI40rLIEhn6XqqSxIs4N16Wq9zLpVKGh5nhBeUOz26S6X308yF-WICzIReGaJXO91uf3ntrd2XstDmel-UY1-GEzAkBf0hVqJJFWCY0QLyukz9vPA8y2LjvsIL7JBruMmcsycs8_qKilYGt4Ek9Vr6KTu8izsU6rDmoyE7t02zAgqk2YWXmfoZvwestWiC7rNhT2TU1o0_wxCllTa7LuiViuu0MwRAf5y8tnti8IWncZrO6sONs_tUL63NajGZ0ZF39jHOgZFkxSaz1jimyjoa5MqztNtxfnN-dTT3XS8FTGNPRjxRBqpVUgZ5QRflUoV_JUhNlEneoCApixEE-NyaOQ5UrKsylfO3ruG_EUWQm3IGlqq7Md2BxFKoU0S6VBYpkwTOpJ9pXUSoR7EQBH8HxoEMxtyUzxMAlexSkcUEaFz4XqPER8EHNYkgGRfdlWreWWhGIdiJ88el9jyB-k_xgMgKjwT9m3P1PuUNYnd7NrsX15c3VHnyjO5Zstg9LXfPbHCA66eSP3vr-Ap_J4jk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=O39.+In+vitro+cellular+radiosensitivity+assays+as+predictor+of+radiotherapy+related+late+toxicity+in+breast+cancer+patients&rft.jtitle=Physica+medica&rft.au=Vandevoorde%2C+C.&rft.au=Depuydt%2C+J.&rft.au=Veldeman%2C+L.&rft.au=De+Neve%2C+W.&rft.date=2016-09-01&rft.pub=Elsevier+Ltd&rft.issn=1120-1797&rft.eissn=1724-191X&rft.volume=32&rft.spage=153&rft.epage=154&rft_id=info:doi/10.1016%2Fj.ejmp.2016.07.047&rft.externalDocID=S1120179716301806 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F11201797%2FS1120179716X00117%2Fcov150h.gif |